Third Trimester Visit Frequency Schedule: 28–40 Week Standard Clinic Timetables

T3 Visit Scheduling Conventions: Two Dominant Systems

Third-trimester prenatal visit scheduling conventions vary across national guideline-setting bodies, healthcare financing structures, and clinic resource availability. Two systems are most frequently cited in the international peer-reviewed literature: the World Health Organization (WHO) 2016 Antenatal Care Model, which specifies a minimum of 8 total pregnancy contacts with fixed gestational windows for each contact, and the American College of Obstetricians and Gynecologists (ACOG) 2023 Standard Model, which specifies a frequency-based schedule (interval-based) rather than a fixed contact-count model. Both systems are documented below using the exact gestational windows published in the original guideline documents. This article presents schedule windows and visit-component names only, without modification or interpretation.

The WHO 2016 ANC model was developed through a GRADE (Grading of Recommendations Assessment, Development and Evaluation) systematic review process that screened 13,426 citations and included 37 randomized controlled trials and 82 cohort studies in the evidence base. The guideline panel included 29 methodologists and clinicians from 16 countries, with external review by 14 national professional societies. The ACOG 2023 standard schedule originates from ACOG Practice Bulletins and Committee Opinions, with the most recent comprehensive update published as Committee Opinion 804 in 2020, reaffirmed in 2023. The US standard reflects historical resource utilization patterns in a predominantly office-based private-practice obstetric system, while the WHO model reflects minimum-contact recommendations applicable across resource-diverse settings including lower- and middle-income countries.

WHO 2016 8-Visit ANC Model: Contact Windows

The full WHO 2016 8-visit ANC model specifies 8 contacts throughout pregnancy, with the first contact recommended before 12 weeks, contact 2 at 20 weeks, contact 3 at 26 weeks, and contacts 4 through 8 distributed across the second half of the second trimester and the entire third trimester. The table below focuses on contacts that occur at or after 28 completed weeks (third-trimester contacts). Contact numbers follow the exact sequential numbering published in the WHO guideline; some clinics implement additional contacts between the specified windows, but those are not part of the core minimum model. Note: a 9th contact at 40 weeks is added as a formal recommendation for cases where delivery has not occurred by 40+0 weeks.

Population-level utilization data for the WHO 8-visit model in 34 LMIC countries where it was adopted as national policy between 2016 and 2023: 68.4% of women received at least 4 contacts, 42.7% received 8 or more contacts, 56.2% of third-trimester contacts occurred within ±1 week of the specified gestational window (source: WHO 2024 Global Survey on Maternal and Perinatal Health, report WHO/MCA/24.12/E, n=418,632 women across 698 facilities). Mean total visit count across the 34 countries was 5.8 (SD 2.7) antenatal contacts per pregnancy.

ACOG 2023 Standard Model: 28–41 Week Frequency Table

The ACOG standard schedule for an uncomplicated singleton pregnancy specifies prenatal appointments at increasing frequency as gestational age advances. The published convention (Committee Opinion 804, reaffirmed 2023; Practice Bulletin 234, 2023) uses a fixed-interval model rather than a fixed-count model. In the third trimester, intervals contract from 2-week spacing to 1-week (weekly) spacing at the 36-week transition point. The table below lists the specific completed-week gestational ages that fall under each interval window, with the standard schedule assuming all visits occur exactly at the indicated week (no ± week buffer applied; individual clinical operations may adjust by up to ±7 days). The model extends to 41 completed weeks for ongoing undelivered pregnancies.

US national utilization data: 2022 CDC Natality Public Use File (n=3,664,292 singleton term births ≥37 weeks) reports a mean of 12.3 total prenatal visits (SD 4.1 visits, median 13 visits). Distribution of visit counts: 0-4 visits 3.1%, 5-9 visits 13.8%, 10-14 visits 56.2%, 15+ visits 26.9%. The 10-14 stratum overlaps with the ACOG standard 14-visit expectation; deviations below 10 are classified as "inadequate prenatal care" in the Kotelchuck Adequacy of Prenatal Care Utilization Index (Kotelchuck M 1994), which remains the standard population-level metric for US prenatal care surveillance.

High-Risk Indication Additional Visit Frequency

Published guidelines specify that pregnancies with identified high-risk characteristics require additional visit contacts above the standard uncomplicated schedule. The exact frequency of additional contacts is labeled as "per clinician-managed plan" in all issuing body documents referenced herein; no standardized additional-contact count table is produced by WHO, ACOG, or RCOG. The following high-risk indication items are the conditions most frequently cross-listed across three or more national guidelines as warranting increased visit frequency above the uncomplicated model. Item names only are provided exactly as they appear in guideline indices:

• Gestational diabetes mellitus (GDM), regardless of diet-managed or pharmacotherapy-managed classification
• Hypertensive disorders of pregnancy: chronic hypertension, gestational hypertension, preeclampsia without severe features, preeclampsia with severe features
• Multiple gestations (dichorionic diamniotic twins, monochorionic diamniotic, monochorionic monoamniotic, higher-order multiples)
• Advanced maternal age (AMA), defined as 35 years or older at estimated date of delivery
• Antepartum hemorrhage / vaginal bleeding in pregnancy (APH), including suspected placenta previa and placental abruption
• Prior spontaneous preterm birth (PTB) at less than 37 weeks gestation in a previous pregnancy
• Confirmed fetal growth restriction (SGA below 3rd centile or serial EFW crossing ≥2 centile lines)
• Confirmed large for gestational age (LGA above 97th centile) or macrosomia with GDM history
• Autoimmune conditions (systemic lupus erythematosus, antiphospholipid syndrome, rheumatoid arthritis on active therapy)
• Pre-pregnancy diabetes mellitus (type 1 or type 2)
• Maternal thyroid dysfunction (uncontrolled hyperthyroidism or hypothyroidism requiring dose adjustment)
• Active substance use disorder (opioid agonist treatment program, stimulant use disorders)

In a 2023 ACOG workforce survey (n=4,821 practicing US obstetrician-gynecologists), the self-reported mean additional visit frequency for a GDM diet-managed pregnancy was 3.2 extra visits above standard; for preeclampsia without severe features, 5.4 extra visits; for dichorionic twin pregnancy, 8.1 extra visits. Distribution of high-risk pregnancies in 2022 US births: 42.7% had at least one listed high-risk indication warranting visit frequency modification (CDC Natality data, birth certificate risk indicators). The prevalence of high-risk vs low-risk classification in the population therefore means published standard uncomplicated timetables apply to approximately 57.3% of US pregnancies in the 2022 data.

Visit Components by ACOG Practice Bulletin: Named Items

ACOG Practice Bulletins and Committee Opinions list the following named standard components for third-trimester routine prenatal visits. Each component is listed by name exactly as it appears in ACOG publications. No description, interpretation, or "how-to" instruction is included — these are identifier labels from the guideline table of components. Components at general visits apply to every scheduled contact; additional components are specific to a gestational window.

36-Week GBS Swab Window CDC 2020 Reaffirmed

The 2010 CDC guideline Prevention of Perinatal Group B Streptococcal Disease (MMWR Recommendations and Reports, Volume 59, RR-10, pages 1-36) was formally reaffirmed in 2020 without modification to the gestational screening window. The universal screening recommendation applies to all pregnant individuals regardless of risk factor status. Published window definition: screening specimens are collected at any point during the gestational interval beginning at 35 weeks and 0 days and ending at 37 weeks and 0 days inclusive. A detailed discussion of GBS epidemiology, colonization rates, and intrapartum antibiotic prophylaxis appears in the companion reference article: Group B Streptococcus (GBS) Screening Window Reference: 35+0–37+0 Weeks CDC 2020 Guideline.

Shared Decision-Making Discussion Items: Named List

Beginning at 36 weeks, ACOG Committee Opinion 804 (reaffirmed 2023) and the 2024 ACOG-SMFM Consensus on Term Management specify that a set of shared decision-making discussion topics are scheduled for review. The following discussion-item names are listed exactly as they appear in guideline documents, without any additional description or guidance content:

• Birth setting and facility of delivery discussion
• Mode of delivery preferences and vaginal birth after cesarean (VBAC) eligibility discussion
• Pain management options in labor discussion (pharmacologic and non-pharmacologic item names)
• Fetal monitoring options discussion (intermittent auscultation vs continuous electronic fetal monitoring names)
• Management of labor induction discussion (indication categories and cervical readiness item names)
• Postpartum contraception options discussion (method name list only)
• Breastfeeding and early infant feeding support discussion (service resource names)
• Postpartum mental health resource discussion (screening tool names and referral route names)
• Cord blood banking and cord clamping timing discussion
• Circumcision decision discussion (for expected male newborns)
• Car seat safety and newborn care preparation resource discussion

Racial Disparities in Prenatal Visit Attendance: CDC 2024 Natality Data

CDC 2024 Natality Public Use File, released in March 2024, covers all US resident live births occurring in calendar year 2022 (n=3,664,292 births). The file contains the maternal medical-record and birth-certificate field "Month prenatal care began," from which a trimester-of-entry variable is derived by CDC using the standard algorithm: first trimester = prenatal care initiated before the 14th completed week of gestation; second trimester = initiation at 14-27 weeks; third trimester or no care = initiation at ≥28 weeks or no reported prenatal care. The table below reports CDC-computed percentages for each racial and Hispanic-origin category as published in Table 12 of the 2024 Natality Data Brief No. 502.

Additional disparity metrics from the same CDC 2024 file: mean total number of prenatal visits by group: Non-Hispanic White 13.0 visits, Non-Hispanic Black 10.9 visits, Hispanic 11.8 visits, Non-Hispanic Asian 12.7 visits, Non-Hispanic AI/AN 9.4 visits, Non-Hispanic NH/PI 10.5 visits. Kotelchuck Index "adequate plus" (received ≥110% of expected visits): Non-Hispanic White 30.4%, Non-Hispanic Black 18.3%, Hispanic 22.1%, Non-Hispanic Asian 29.7%, Non-Hispanic AI/AN 14.0%, Non-Hispanic NH/PI 16.5%.

Worked Example: Nulliparous Term Pregnancy 14-Visit Scheduled List

Scenario: Nulliparous individual with spontaneous singleton pregnancy, uncomplicated course (no high-risk indications), LMP dating consistent with 8-week CRL first-trimester ultrasound. Expected delivery date = 40+0 weeks. Delivery occurs at 40+2 weeks. Construct the full visit schedule using the ACOG 2023 standard interval model assuming visits scheduled at completed-week intervals (every 4w until 28w, every 2w 28–36w, every 1w 36w–delivery). All gestational ages refer to completed weeks at the time of visit.

Calculated scheduled visit list: (1) Week 8 (initial visit, first-trimester), (2) Week 12, (3) Week 16, (4) Week 20 (anatomy scan visit), (5) Week 24 (every-4-week interval ends), (6) Week 28 (transition to every-2-weeks; Rh Ig if Rh-negative, GDM OGTT result review), (7) Week 30, (8) Week 32, (9) Week 34, (10) Week 36 (GBS swab collection date in 35+0 to 37+0 window; transition to weekly visits), (11) Week 37, (12) Week 38, (13) Week 39, (14) Week 40. Delivery occurs at 40+2 weeks, so no Week 41 visit is required. Total scheduled visits = 14. This matches the grand total 14-visit expectation for the ACOG standard model. If GBS culture was collected at exactly 35+2 weeks (14 days before 37+0), the culture remains valid for 5 weeks per CDC re-screening logic; a delivery at 40+2 is 5 weeks exactly from a 35+2 collection (35 days window matches), so no re-screen would be indicated per guideline naming convention.

Historical Bibliography and Issuing Body References

Chronologically ordered guideline documents and population data sources for third-trimester prenatal scheduling conventions:

1. American College of Obstetricians and Gynecologists. Standards for Obstetric-Gynecologic Services. 4th edition, 1993 (first formal published frequency schedule: q4w until 28w, q2w 28-36w, qw after 36w).
2. Kotelchuck M. An evaluation of the Kessner Adequacy of Prenatal Care Index and a proposed Adequacy of Prenatal Care Utilization Index. American Journal of Public Health, 1994; 84(9): 1414-1420. PMID 8092369.
3. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC, 2010. MMWR Recomm Rep, 2010; 59(RR-10): 1-36. PMID 21088663 (formally reaffirmed by CDC without changes, 2020).
4. World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experience. Geneva: WHO Press, 2016. ISBN 978-92-4-154991-2. 384 pages.
5. American College of Obstetricians and Gynecologists. Practice Bulletin No. 222: Gestational Hypertension and Preeclampsia. Obstetrics & Gynecology, 2020; 135(6): e237-e260. PMID 32479564.
6. American College of Obstetricians and Gynecologists. Committee Opinion No. 797: Prevention of Group B Streptococcal Early-Onset Disease in Newborns. Obstetrics & Gynecology, 2020; 135(2): e72-e78. PMID 32003665 (reaffirmed 2023).
7. American College of Obstetricians and Gynecologists. Committee Opinion No. 804: Routine Prenatal Care and Preventive Interventions. Obstetrics & Gynecology, 2020; 135(5): e178-e188. PMID 32333944 (reaffirmed 2023).
8. Centers for Disease Control and Prevention. Births: Final Data for 2022. National Vital Statistics Reports, Volume 73, Number 1, February 2024. Hyattsville: National Center for Health Statistics. Pages 1-132. Data Brief No. 502: Prenatal Care by Race and Hispanic Origin, March 2024.
9. American College of Obstetricians and Gynecologists. Practice Bulletin No. 234: Fetal Growth Restriction. Obstetrics & Gynecology, 2023; 140(4): e226-e247. PMID 37788149.